Aarhus University Hospital is a university hospital located in Aarhus, Denmark. The hospital develops and provides highly specialised medical treatment, research and education at an international level.

There are 1,150 beds in Department of Hematology, Aarhus University Hospital.

During the past decade, Department of Hematology, Aarhus University Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Hematology, Aarhus University Hospital" #1 sponsor was "Henrik Gregersen" with 2 trials, followed by "Nordic Lymphoma Group" with 2 trials sponsored, "Nordic MDS Group" with 2 trials sponsored, "Nordic Myeloma Study Group" with 2 trials sponsored and "University of Aarhus" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Hematology, Aarhus University Hospital" #1 collaborator was "Danish Myeloma Study Group" with 2 trials as a collaborator, "Janssen-Cilag Ltd." with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Department of Hematology, Aarhus University Hospital" are "Multiple Myeloma" (4 trials), "MDS" (2 trials), "AML" (1 trials), "DLBCL" (1 trials) and "Diffuse Large B Cell Lymphoma" (1 trials). Many other conditions were trialed in "Department of Hematology, Aarhus University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Hematology, Aarhus University Hospital" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Clarithromycin" (2 trials), "Fludarabine" (1 trials), "Observation" (1 trials), "PREBEN" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Hematology, Aarhus University Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Department of Hematology, Aarhus University Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Department of Hematology, Aarhus University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Hematology, Aarhus University Hospital, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".